{"identifier":"nobleid:/w1/20260525/82211653","arkIdentifier":"ark:/48914/w1/20260525/82211653","version":1,"workTitle":"Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR).","workType":"Journal Article","authors":"Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami","description":null,"workUrl":null,"createdAt":"2026-05-25T22:13:36.007664Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260525/82211653.v1"}